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Abstract 24 
Objective: To assess the agreement between detected changes in body composition 25 
determined by bioimpedance spectroscopy (BIS) and air-displacement plethysmography 26 
(ADP) amongst cancer patients undergoing peripheral blood stem cell transplantation 27 
(PBSCT); to assess the agreement of absolute values of BIS with ADP and dual energy x-ray 28 
(DXA). Methods: Forty-four adult haematological cancer patients undergoing PBSCT 29 
completed both BIS and ADP assessment at pre-admission and at three months post-30 
transplantation. Body composition was assessed using BIS (ImpSFB7, Impedimed, Brisbane, 31 
Australia) and ADP (BOD POD, COSMED, Concord, CA, USA). A subsample (n=11) were 32 
assessed by DXA (Hologic, QDR 4500A fan-beam scanner, MA, USA) at post-transplantation. 33 
Results were examined for the BIS instrument’s default setting and three alternative 34 
predictive equations from the literature. Agreement was assessed by the Bland-Altman 35 
limits of agreement analysis while correlation was examined using the Lin’s concordance 36 
correlation. Results: Changes in body composition parameters assessed by BIS were 37 
comparable to those determined by ADP regardless of the predictive equations used. Bias of 38 
change in fat free mass was clinically acceptable (all <1 kg), although limits of agreement 39 
were wide (> ±6kg). Overall, the BIS predictive equation accounting for body mass index 40 
performed the best. Absolute body composition parameters predicted by the alternative 41 
predictive equations agreed with DXA and ADP better than the BIS instrument’s default 42 
setting. Conclusion: Changes predicted by BIS were similar to those determined by ADP at a 43 
group level, however, changes at an individual level should be interpreted with caution due 44 
to wide limits of agreement. 45 
Key Words: Body composition, stem cell transplantation, cancer, air-displacement 46 
plethysmography, bioelectrical Impedance, spectroscopy 47 
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Introduction 49 
Unintentional weight loss and a decline in nutritional status are frequently reported 50 
amongst cancer patients due to a combination of treatment side effects or the disease itself.  51 
Change in the proportion of fat mass (FM) and fat-free mass (FFM) can be variable 52 
depending on the type and stage of disease. Impaired FFM needs to be identified because 53 
unfavourable body composition changes are associated with adverse clinical outcomes such 54 
as mortality [1], reduced functioning, and poorer quality of life [2]. In a previous study 55 
conducted by the authors [3], reduced nutritional status was accompanied by a concurrent 56 
loss of LBM, and reduced quality of life after a group of cancer patients underwent PBSCT. 57 
Bioimpedance technology such as bioimpedance spectroscopy (BIS) is a portable, 58 
computerized technology for body composition assessment that is non-invasive and easy to 59 
operate and relatively inexpensive. This technology provides accurate results amongst 60 
healthy subjects [4, 5] but a limited number of studies have examined its validity amongst 61 
the cancer population and the inter-changeability of BIS with other laboratory measures. 62 
How portable devices such as BIS compare with laboratory methods such as dual-energy X-63 
ray absorptiometry (DXA), and air-displacement plethysmography (ADP) is of interest 64 
because compliance to routine assessments requiring complex procedures or low 65 
convenience (i.e. need to travel) can be challenging amongst critically-ill patients.  66 
In this study, the body composition of adult cancer patients treated with peripheral blood 67 
stem cell transplantation (PBSCT) was examined.  The aims of this study were to compare 68 
the agreement of absolute values estimated by BIS relative to ADP, and DXA; and changes in 69 
body composition detected by BIS relative to ADP at three months post-PBSCT. 70 
Methods 71 
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Subjects were haematological cancer patients treated with PBSCT at a single transplant 72 
centre, the Haematology and Oncology Clinics of Australia, The Wesley Hospital, Brisbane, 73 
Australia. Sixty-five subjects were scheduled to complete ADP and BIS assessment up to two 74 
weeks before PBSCT (pre-admission), and at three months post-PBSCT; 44 subjects 75 
completed assessments at both time points; 11 out of the 44 subjects completed a once-off 76 
DXA scan. Ethical approval was granted by the Multidisciplinary Ethics Committee of the 77 
hospital (Ref: 1107, and Ref: 1017) and Medical Research Ethics Committee of The 78 
University of Queensland (HMS10/0306.r1 and HMS11/2405). 79 
All subjects wore a tight fitting, one-piece Lycra
®
 suit and a Lycra cap provided by the lab. 80 
Height was measured to the nearest 0.1 cm using a wall-mounted stadiometer, and weight 81 
was measured to the nearest 0.1 kg (TBF-300A, Tanita Inc, Tokyo, Japan). BIS, followed by 82 
ADP measurements were completed within a 15-minute period.  83 
Bioimpedance spectroscopy 84 
Participants were assessed with whole body BIS (ImpSFB7, Impedimed, Brisbane, Australia). 85 
The theories and principles of bioimpedance techniques have been detailed previously [6]. 86 
In short, body composition is derived from impedance which measures the decrease in 87 
voltage of an applied electric current due to resistance in the human body (i.e. non-88 
conductive tissues such as fat). For each assessment, this BIS device obtains impedance data 89 
across a spectrum of 256 frequencies between 3 to 1000 kHz. Prediction of body 90 
composition was performed by fitting the impedance data to the Cole-Cole model to 91 
determine resistance at zero and infinite frequencies using manufacturer’s software. These 92 
resistance values were then applied to Hanai mixture theory equations to predict total body 93 
water, FFM and FM [6, 7]. Hanai mixture theory equations require the input of values for 94 
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resistivities of intra- and extracellular water, a body proportion correction factor (Kb), body 95 
density (Db) and lean tissue hydration fraction to predict body fat-free mass from the 96 
predicted TBW [8]. Body composition estimates from BIS data are therefore dependent 97 
upon the values chosen for these parameters. For SFB7, the coefficient of variation for 98 
repeated measures has been determined as <0.5% [9]. Estimates of body composition were 99 
predicted using the default parameters provided with the instrument, those of: de Lorenzo 100 
et al. [7] and Matthie et al. [10];  Moissl et al. [11]; and produced by the authors in an 101 
independent study [12]. The electrode configuration for whole-body assessment has been 102 
described previously [6].  103 
Air-displacement plethysmography 104 
ADP was conducted using a BOD POD unit (COSMED, Concord, CA, USA). ADP is considered 105 
as an alternative to underwater weighing; it is based on the two compartment model which 106 
separates the body into two distinct chemical components composed of FFM and FM [13]. 107 
The principles of ADP have been detailed elsewhere [14]. FFM and FM can be derived from 108 
volume, density and weight using the equation for the general population by Siri [15]. 109 
Predictive thoracic gas volume inbuilt in the BOD POD software was used.  110 
The system is composed of a fibreglass chamber that measures body volume and an 111 
external electronic scale that measures weight. The chamber volume is calibrated daily, 112 
while the scale is calibrated fortnightly; calibration is performed using the manufacturer-113 
provided calibration cylinder (50.099 L) and calibration weights (20 kg) respectively. Two to 114 
three repeated measurements were conducted for each participant as instructed by the 115 
computer. Participants remained still for each measurement which lasted less than a 116 
minute.  117 
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Dual energy X-ray (DXA) absorptiometry 118 
Body composition was assessed with whole-body DXA scan (Hologic, QDR 4500A fan-beam 119 
scanner, MA, USA) and adult software version 13.3. Daily calibration was performed with 120 
phantom spine, and steps provided by the manufacturer. The theories and principles of DXA 121 
have been detailed previously [16]. In summary, body composition is determined through 122 
the measurement of mass attenuation coefficients, the ratio values, image processing, and 123 
soft tissue distribution models. Body composition was calculated by algorithms provided by 124 
the manufacturer (Bioimp, software version 5.3.1.1) [17]. 125 
Participants wore light clothing; all metal objects were removed (i.e. jewellery, glasses, zips). 126 
Participants were instructed to remain still for up to 7 minutes during the scan.  127 
Statistical Analyses 128 
Statistical analysis was performed using SPSS version 20.0.0 (IBM SPSS statistics, Chicago, IL, 129 
USA). Normality was tested with Shapiro-Wilk’s test. Descriptive statistics were calculated 130 
for baseline characteristics (age, and BMI), and body composition parameters at different 131 
time points. Paired t-test was used to assess the mean differences between body 132 
composition parameters measured by BIS relative to ADP or DXA. Bland-Altman approach 133 
was used to assess the agreement between ADP and BIS; limits of agreement (LOA) were 134 
calculated as ± two standard deviations of bias [18]. Correlation between results of the 135 
methods was assessed with Lin’s concordance correlation [19]. Statistical significance was 136 
reported at the conventional p < 0.05 level (two-tailed). A clinically acceptable difference for 137 
FFM between the methods was defined a priori as ≤1 kg [20].  138 
Results 139 
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Sixty-five subjects were included in this study; 44 subjects (52.3% male) who completed 140 
both baseline and follow-up assessment at three-month post-transplantation were 141 
analysed.  142 
Non-completion of assessments was mainly due to inconvenience to travel to the hospital in 143 
the desired time frame. 144 
Median age was 56.5 years-old (range 22-75 y), and median BMI was 28.0 kg/m
2
 (range 145 
16.4–47.6 kg/m
2
); 36.4% of the subjects were overweight (BMI 25 to <30 kg/m
2
), 31.8% 146 
were of normal weight (BMI 18.5 to <25 kg/m
2
), 29.5% were obese (BMI >30 kg/m
2
), and 147 
2.3% was underweight (BMI <18.5 kg/m
2
)[21]. Results of ADP showed FFM (kg) was higher 148 
amongst males (p < 0.001). In the sub-group of participants (n=11/44) who underwent DXA 149 
examination, both FFM and FM predicted by DXA relative to ADP was not significantly 150 
different (FFMDXA-ADP = -0.91kg ± LOA 4.2, p = 0.186; FMADP-DXA 1.39 kg ± LOA 4.2, p = 0.055). 151 
Mean weight loss amongst obese subjects (-7.1 ± 4.9 kg) was significantly higher than 152 
normal or underweight subjects (-2.9 ± 3.4 kg) (p = 0.032) but similar to overweight subjects 153 
(-4.3 ± 4.3 kg) (p = 0.235); there was no difference in weight loss between males and 154 
females (p = 0.275), and younger or older group (age ≤60 and >60 y) (p = 0.272). 155 
Different BIS prediction methods produced different absolute values for FFM and FM (Table 156 
1). Results obtained using the alternative BIS predictive equations were generally in 157 
agreement, e.g. predicted FFM at baseline varied by only 3.2 %, whereas the default 158 
instrument predictions were in poorer agreement with ADP values and those obtained using 159 
the alternative BIS predictive equations. Notably, however, the changes in body 160 
composition from baseline to post-PBSCT measured by BIS were similar irrespective of the 161 
prediction method used. This is explored further below.  162 
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Agreement of absolute values  163 
Since the alternative predictive equations performed similarly, results in Table 2 are shown 164 
for default instrument and Moissl et al. [11] methods only. 165 
Although the results predicted by Ward et al. [12] (i.e. difference FFM -2.2 kg (CI95% -3.6, -166 
0.8), p = 0.003) and Moissl et al. [11] (i.e. difference FFM -1.2 kg, CI 95% -2.3, -0.2, p = 0.021) 167 
at baseline, and  Ward et al. [12] prediction at post-transplant (i.e. difference FFM -1.4 kg, CI 168 
95% -2.8, 0.0, p = 0.045) were significantly different to ADP, the agreement relative to ADP 169 
were better compared to the instrument’s default setting. Results predicted by De Lorenzo 170 
et al. [7] method were not significantly different relative to ADP at both time points.  171 
Results predicted by the BIS alternative predictive equations agreed well (all p > 0.05) with 172 
DXA, whereas results predicted by the default setting was significantly different (all p ≤ 173 
0.001).  174 
Limits of agreement were wide for all comparisons (i.e. LOA ± 7 to LOA ±11 kg for both FFM 175 
and FM). 176 
Agreement of detected changes (Δ) before and after transplantation 177 
Predicted ΔFFM and ΔFM (Table 2) by ADP and all BIS methods were similar but limits of 178 
agreement were wide. The method by Moissl et al. [11] performed the best (mean bias 179 
ΔFFM = 0.29 kg, LOA ± 6.4 kg, p = 0.547), followed by Ward et al. [12] (mean bias ΔFFM = 180 
0.75 kg LOA ± 6.6 kg, p = 0.138), De Lorenzo et al. [7] (mean bias ΔFFM = 0.91 kg, LOA ± 8.4 181 
kg, p = 0.160), and lastly the default setting (mean bias ΔFFM = 0.92 kg, LOA ± 7.2 kg, p = 182 
0.101). 183 
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Correlation 184 
The strength of correlation between results measured by BIS and ADP was based on the 185 
criteria proposed by McBride et al. [22]. Absolute FFM, and FM measured by the default 186 
setting correlated poorly (all strength < 0.90) with ADP; in contrast, absolute FFM and FM 187 
measured by the alternative BIS predictive equations correlated moderately (strength 0.90-188 
0.95) to substantially (strength 0.95-0.99), but poorly for percentage FM (strength <0.90). 189 
Correlations for ΔFFM, ΔFM, and Δ%FM were poorer for all methods (strength 0.16-0.61). 190 
 Bland-Altman plots 191 
Bland-Altman plots of absolute value at pre-admission and three months post-192 
transplantation were similar. For ease of presentation, only the plots for pre-admission 193 
comparison are presented for the BIS default setting and Moissl et al. [11] method. Figure 194 
1a shows the default setting overestimated FFM relative to ADP and bias increases as FFM 195 
increases. Figure 1b shows the Moissl et al. [11] method overestimated FFM slightly but the 196 
trend of increase or decrease in bias towards extreme ends of FFM is less pronounced. 197 
Similar trends were observed for FM (plots not shown). Figure 2a and Figure 2b are Bland-198 
Altman plots showing ΔFFM detected by the default setting and Moissl et al. [11] method 199 
compared to ADP. Regardless of the direction of change, disagreement between the default 200 
setting and ADP tended to increase as the magnitude of change increased. Mean bias was 201 
slightly improved when results were re-analysed with the Moissl et al. [11] method but a 202 
similar trend of increase in bias was observed for increased changes in FFM. Bland-Altman 203 
plots showed similar systematic variation for the bias ΔFM for both methods (plots not 204 
shown).  205 
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Discussion 206 
This study is the first to examine the agreement of body composition methods amongst 207 
cancer patients treated with PBSCT.  This study found a portable device such as BIS was 208 
sensitive enough to detect changes in body composition comparable to that assessed by 209 
ADP amongst cancer patients who experienced moderate weight loss at three months after 210 
PBSCT. Agreement at a group level (mean bias) for detected changes in FFM was clinically 211 
acceptable (<1 kg) although limits of agreement were wide as observed in other studies [23-212 
27]. 213 
 214 
Relative to ADP and DXA, the agreement of absolute values predicted by the default setting 215 
was poor. Similar findings were reported in other cancer studies that examined cross-216 
sectional results [28, 29].  217 
 218 
No cancer studies which examined the agreement between predicted changes in 219 
longitudinal studies could be identified in the literature. However, studies on overweight or 220 
obese subjects (without cancer) demonstrated that portable methods such as bioimpedance 221 
devices can accurately measure changes in the body composition parameters after weight 222 
loss regardless of large discrepancies between cross-sectional results [24-27, 30, 31].   223 
 224 
Absolute results of FFM tend to be overestimated by the BIS default setting which was 225 
similar to studies examining healthy subjects [32, 33], overweight or obese subjects, [24, 31, 226 
34] and subjects with clinical conditions [23, 28]. When BIS results were re-analysed with 227 
the methods by De Lorenzo et al. [7], Ward et al. [12], and Moissl et al. [11], the agreements 228 
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of absolute results relative to ADP improved substantially. Bland-Altman plots showed the 229 
systematic variation in the bias of FFM relative to ADP observed for the BIS default setting 230 
(Figure 1a) was reduced when BIS results were re-analysed using the method by Mossil et al. 231 
[11] (Figure 1b). A similar effect was observed for FM (plots not shown). 232 
 233 
For the agreement in ΔFFM (Figures 2a and 2b) however, the method of Moissl et al. [11] 234 
did not reduce the systematic variation in the bias of ΔFFM observed in the BIS default 235 
setting. Changes in body hydration or altered composition of FFM may explain the increase 236 
in discrepancy as weight loss or weight gain increases [35]. The BIS method, unlike 237 
empirically-derived prediction equations, predicts body water volumes based on 238 
fundamental equations incorporating the resistivity of body fluids (ECW and ICW) [7, 8]. 239 
However, transformation of TBW to FFM assumes a hydration fraction and is therefore 240 
prone to error when hydration state changes. At the time of study, the participants were 241 
nutritionally stable and unlikely to be dehydrated. Other variables (i.e. disproportion loss of 242 
FFM or FM) specific to our population may be present.  243 
 244 
The limits of agreement for ΔFFM or ΔFM in this study were 2 to 4 kg wider than some 245 
reported in the literature [24, 25, 27]. These differences may be due to sample 246 
characteristics as subjects in these studies were younger, healthy participants undergoing 247 
intentional weight loss program; three of these studies were composed of females only 248 
while one analysed by gender separately. For each of the BIS methods, we examined bias 249 
and limits of agreement separately by gender, age group (≥ 60 y and < 60 y) and BMI 250 
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categories. Results were not significantly different for the Moissl et al. [11] method, 251 
however, results predicted by the default setting, Ward et al. [12] and De Lorenzo et al. [7] 252 
became significantly different to ADP for female subjects (p<0.05), and younger subjects ≤60 253 
years old (p<0.05). Results showed Moissl et al. [11] method is more suitable for the 254 
assessment of samples with mixed characteristics (i.e. gender, age, and BMI) than the other 255 
BIS methods in this study. Owing to wide limits of agreement, ADP and BIS are not 256 
interchangeable; routine assessments on the same individual should be conducted with the 257 
same method consistently. 258 
 259 
There is currently no population-specific resistivity coefficient or recommendation on the 260 
type of BIS equation suitable for the assessment of body composition of patients treated 261 
with PBSCT.  Results of this study showed the default setting is not optimal for assessing the 262 
PBSCT population since alternative predictive equations produced better agreement with 263 
the reference method. Absolute (i.e. cross-sectional) results should be interpreted with 264 
caution as results vary greatly with the choice of predictive equations and the characteristics 265 
of the subjects being assessed [36]. Notably, for example in the present study, BIS 266 
prediction, when analysed using the method of Moissl et al. [11] performed significantly 267 
better than when the BIS default settings were used. The Moissl et al. [11] approach 268 
specifically takes account of the variation of impedance-based predictions of body 269 
composition with BMI; our population was skewed toward subjects who were either 270 
overweight (36.4%) or obese (29.5%).  271 
 272 
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There are no similar studies amongst the cancer population; most studies compared cross-273 
sectional results only. This study has highlighted that the accuracy of BIS for prediction of 274 
absolute body composition is dependent upon the choice of appropriate values for 275 
coefficients in the predictive equations; the default settings of BIS cannot be relied upon. It 276 
should be noted, however, that these settings may be changed by the user. Considering 277 
changes in body composition parameters have more clinical meaning than results collected 278 
at a single time point, it would be of great interest for future studies to compare more 279 
thoroughly the validity of detected changes in body composition rather than the agreement 280 
of cross-sectional results alone. Different predictive equations should be explored. In this 281 
regard, all BIS methods were observed in the present study to predict similarly change in 282 
body composition both in direction and magnitude; these predictions were also similar to 283 
those determined by ADP. Further studies are needed to confirm the sensitivity of BIS in 284 
tracking body composition changes relative to other laboratory methods, as well as amongst 285 
other clinical populations with varying degrees of weight loss. 286 
 287 
Strengths and limitations 288 
This study provides new information as it is the first to examine the agreement of body 289 
composition methods amongst PBSCT patients. Our study had a moderate sample size 290 
considering studies examining detected body composition changes had sample sizes of less 291 
than 60 [25-27, 30, 31];  these studies included healthy overweight subjects participating in 292 
weight loss programs whereas our subjects were cancer patients; it is more challenging to 293 
obtain large sample in prospective studies particularly amongst the cancer populations.  294 
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 295 
A limitation of this study was that DXA could only be performed at one time point amongst a 296 
small number of participants because the instrument was located at a different site; the 297 
distance of travel had an effect on compliance. The 32% (n=21/65) of patients who were not 298 
included in this study due to incomplete body composition data may bias the results if they 299 
had different degree of FFM and FM change compared to patients included in this study.  300 
 301 
Conclusion 302 
Amongst patients treated with PBSCT, the BIS approach to prediction of FFM and FM, 303 
particularly the Moissl method [11], was highly correlated with body composition 304 
determined by ADP although the bias and limits of agreement were large for the SFB7 305 
default method. The Moissl method [11] was in closer agreement with ADP but the 306 
relatively large limits of agreement may preclude its use in individuals.  With respect to 307 
changes in FFM and FM, changes predicted by BIS were similar to those determined by ADP 308 
at a group level, however, agreement at an individual level should again be interpreted with 309 
caution due to wide limits of agreement. 310 
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Table 1 Body composition parameters (mean ±SD) measured at pre-admission and at 426 
three months after peripheral blood stem cell transplantation N=44.  427 
Variable  
Pre-admission 
 
Post-PBSCT 
 
Detected change 
 
Weight (kg)  81.5 ± 19.7 76.8 ± 18.1 -4.6 ± 4.5 
     
FFM(kg)ADP  49.4 ± 10.9 48.4 ± 10.9
 
-1.0 ± 1.9
 
 
FM (kg) ADP  32.1 ± 14.4 28.5 ± 12.7 -3.6 ± 3.9 
%FM ADP  38.3 ± 9.9 36.1 ± 9.4 -2.2 ± 3.3 
     
FFM(kg) BIS SFB7 default 55.9 ± 13.4
6
 54.0 ± 13.2
6 
-1.9 ± 4.6 
FM (kg) BIS  25.6 ± 11.0
6
 22.8 ± 10.5
6
 -2.8 ± 3.2 
%FM BIS  38.3 ± 9.9
6
 29.2 ± 8.7
6
 -1.7 ± 3.8 
     
FFM(kg) BIS De Lorenzo et al.
1 
50.2 ± 13.8 48.3 ± 13.9 -1.9 ± 5.2 
FM (kg) BIS  31.3 ± 11.8 28.5 ± 11.2 -2.8 ± 3.7 
%FM BIS  38.3 ± 8.9 37.1 ± 9.7 -1.2 ± 4.2 
     
FFM(kg) BIS Ward et al.
2 
51.6 ± 13.4
5
 49.9 ± 13.4
 5
 -1.7 ± 4.3 
FM (kg) BIS  29.9 ± 11.7
5
 27.0 ± 10.9
 5
 -2.9 ± 2.9 
%FM BIS  36.4 ± 8.5
5
 35.0 ± 9.0
 
 -1.5 ± 3.2 
     
FFM(kg) BIS Moissl et al.
3 
50.6 ± 11.7
5
 49.4 ± 11.9 -1.3 ± 4.1 
FM (kg) BIS  30.9 ± 13.2
5
 27.5 ± 12.2 -3.4 ± 3.3 
%FM BIS  37.0 ± 9.1
5
 35.0 ± 9.6 -2.02 ± 3.5 
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FFM(kg) DXA
 4
  NM 50.2 ± 9.5 NM 
FM (kg) DXA
 4
  NM 25.7 ± 9.1 NM 
%FM DXA
 4
  NM 33.0 ± 6.1 NM 
1
De Lorenzo et al. [7] 428 
2
Ward et al. [9] 429 
3
Moissl et al. [11] 430 
4
N=11 431 
5
p < 0.05, difference compared to ADP, paired t-test 432 
6
p < 0.001, difference compared to ADP, paired t-test 433 
Abbreviations: ADP, air displacement plethysmography; BIS, bioimpedance spectroscopy; DXA, dual-434 
energy X-ray absorptiometry; FFM, fat free mass; FM, fat free mass, NM, not measured; PBSCT, 435 
peripheral blood stem cell transplantation. 436 
437 
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Table 2 Mean bias (95%CI) and limits of agreement for fat free mass (kg), fat mass (kg), and 438 
percentage (%) fat mass, at pre-admission, and at three months after peripheral blood stem cell 439 
transplantation as measured by bioimpedance spectroscopy relative to air-displacement 440 
plethysmography, and dual-energy X-ray absorptiometry N=44.  441 
Comparison  Bias (95%CI) 
Limits of 
Agreement 
5
Correlation 
r  
Baseline 
FFM (kg) ADP – BIS
 
  -6.5 (-8.0, -5.0)
4
 ± 9.9 0.80 
FM (kg) ADP – BIS
 
 SFB7 default 6.5 (5.0, 7.9)
4
 ± 9.8 0.82 
FM (%) ADP – BIS
 
  7.3 (5.7, 8.8)
4 
± 10.2 0.63 
FFM (kg) ADP – BIS
 
  -1.2 (-2.3, -0.2)
 3
 ± 6.8 0.95 
FM (kg) ADP – BIS
 
 Moissl et al.
1 
1.2 (0.2, 2.3)
 3
 ± 6.8 0.97 
FM (%) ADP – BIS
 
  1.2 (0.0, 2.4)
 3
 ± 7.9 0.91 
Post-transplantation 
FFM (kg) ADP – BIS
 
  -5.6 (-7.0, -4.2) 
4
 ± 9.1 0.84 
FM (kg) ADP – BIS
 
 SFB7 default 5.7 (4.3, 7.1)
 4
 ± 9.2 0.82 
FM (%) ADP – BIS
 
  6.9 (5.4, 8.4)
 4
 ± 10.0 0.65 
FFM (kg) ADP – BIS
 
  -0.9 (-2.1, 0.2) ± 7.3 0.95 
FM (kg) ADP – BIS
 
 Moissl et al.
 1
 1.0 (-0.1, 2.1) ± 7.5 0.95 
FM (%) ADP – BIS
 
  1.1 (-0.4, 2.5) ± 9.6 0.87 
FFM (kg) DXA - BIS
 2
  -5.9 (-8.7, -3.0)
 4
 ± 8.4 0.81 
FM (kg) DXA - BIS
 2
 SFB7 default 5.1 (2.4, 7.8)
3
 ± 8.0 0.69 
FM (%) DXA - BIS
 2
  6.3 (3.1, 9.5)
 4
 ± 9.5 0.33 
FFM (kg) DXA – BIS
 2 
  -1.5 (-3.2, 0.1) ± 4.9 0.96 
FM (kg) DXA – BIS
 2
 Moissl et al.
 1
 0.7 (-0.7, 2.2) ± 4.3 0.96 
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FM (%) DXA – BIS
 2
  0.9  (-1.3, 3.1) ± 6.7 0.79 
Detected changes 
ΔFFM (kg) ADP – BIS  0.92 (-0.19, 2.02) ± 7.2 0.45 
ΔFM (kg) ADP – BIS SFB7 default -0. 76 (-1.87, 0.35) ± 7.3 0.47 
ΔFM (%) ADP – BIS  0.40 (-1.68, 0.87) ± 8.4 0.31 
ΔFFM (kg) ADP – BIS  0.29 (-0.68, 1.27) ± 6.4 0.50 
ΔFM (kg) ADP – BIS Moissl et al.
 1
 -0.22 (-0.68, 1.27) ± 6.3 0.61 
ΔFM (%) ADP – BIS  -0.16 (-1.32, 0.99) ± 7.6 0.37 
1
Moissl et al. [11] 442 
2
n = 11 443 
3
p < 0.05, difference between methods, paired t-test 444 
4
p < 0.001, difference between methods, paired t-test 445 
5
Lin’s concordance correlation coefficient 446 
Abbreviations: ADP, air displacement plethysmography; BIS, bioimpedance spectroscopy; DXA, dual-447 
energy X-ray absorptiometry; FFM, fat free mass; FM, fat free mass; Δ, change between baseline and 448 
post-transplantation. 449 
 450 
 451 
 452 
453 
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Figure 1. Bland-Altman plot of absolute fat free mass in kg (FFM) at pre-admission as predicted by (a) 454 
bioimpedance spectroscopy default setting (BIS default), and (b) Moissl et al. method, relative to air 455 
displacement plethysmography (ADP). Mean bias (solid line) and ±2SD (dashed lines). 456 
 457 
Figure 2. Bland-Altman plot of change in fat free mass in kg (ΔFFM) between pre-admission and 458 
three months after stem cell transplantation as predicted by (a) bioimpedance spectroscopy default 459 
setting (BIS default), and (b) by Moissl et al. method, relative to air displacement plethysmography 460 
(ADP). Mean bias (solid line) and ±2SD (dashed lines). 461 
 462 
 463 
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